DP Devanand
Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name DP Devanand as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02129348 · Treatment of Psychosis and Agitation in Alzheimer's DiseaseNew York State Psychiatric Institute · completed · Alzheimer's Disease, Psychosis, Agitation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 17:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Treatment of psychosis and agitation in Alzheimers diseaseR01AG047146 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI DAVANGERE P DEVANAND · fiscal years 2014 to 2018Named on NCT02129348
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 17:01 UTC. The ranking covers the 200 most relevant of 78 PubMed records, and a shared surname and initials can bring in a namesake. All 78 on PubMed
- Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.N Engl J Med · 1993740 citationsRCR 32.9
- A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.Arch Gen Psychiatry · 2000580 citationsRCR 19.4
- Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.Brain Stimul · 2008399 citationsRCR 14.1
- Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.JAMA · 2014389 citationsRCR 15.9
- Late-life depression, mild cognitive impairment, and dementia.JAMA Neurol · 2013295 citationsRCR 11.5
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.J Alzheimers Dis · 2016228 citationsRCR 8.5
- The effects of electroconvulsive therapy on memory of autobiographical and public events.Arch Gen Psychiatry · 2000211 citationsRCR 6.9
- Predictors of retrograde amnesia following ECT.Am J Psychiatry · 1995200 citationsRCR 8.4
- A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.Am J Psychiatry · 1998168 citationsRCR 5.9
- The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome.Arch Gen Psychiatry · 1996146 citationsRCR 5.0